# A Study of SHR-4375 in Subjects With Solid Tumors

> **NCT06764628** · PHASE1,PHASE2 · RECRUITING · sponsor: **Suzhou Suncadia Biopharmaceuticals Co., Ltd.** · enrollment: 208 (estimated)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** SHR-4375

## Key facts

- **NCT ID:** NCT06764628
- **Lead sponsor:** Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-09
- **Primary completion:** 2027-05
- **Final completion:** 2027-05
- **Target enrollment:** 208 (ESTIMATED)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06764628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06764628, "A Study of SHR-4375 in Subjects With Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06764628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*